An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR).
Stephen Ian WalimbwaJulian P KaboggozaCatriona WaittPauline Byakika-KibwikaAntonio D'AvolioMohammed LamordePublished in: Trials (2021)
ClinicalTrials.gov NCT04385719 . Registered 13 May 2020.